课题基金 / 基金详情

TO AWARD THE BASE PERIOD FOR NIMH PSYCHOACTIVE DRUG SCREENING PROGRAM (PDSP). BASE POP: 08/30/2023-08/29/2024.

TO AWARD THE BASE PERIOD FOR NIMH PSYCHOACTIVE DRUG SCREENING PROGRAM (PDSP). BASE POP: 08/30/2023-08/29/2024.
授予 NIMH 精神活性药物筛查计划 (PDSP) 基期。
批准号：
10931140
负责人：
BRYAN ROTH
金额：
$309.75万
依托单位：
UNIV OF NORTH CAROLINA CHAPEL HILL
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
项目状态：
已结题
起止时间：
2023-08-30 至 2024-08-29
来源：
https://reporter.nih.gov/project-details/10931140
关键词：
AwardBasic ScienceBrain imagingClinical ResearchFunctional Magnetic Resonance ImagingImaging ligandsMental disordersNational Institute of Mental HealthNatural ProductsPositron-Emission TomographyPsychotropic DrugsResearchTherapeutic Agentsbasenovelscreeningscreening programsingle photon emission computed tomographytool

项目摘要

项目成果

BRYAN ROTH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of the NIMH PDSP is to provide screening of novel synthetic compounds and natural products for potential use as research tools or probes for basic and clinical research, as therapeutic agents for mental disorders, and as positron emission tomography (PET), single photon emission computed tomography (SPECT), and functional magnetic resonance imaging (fMRI) ligands for functional brain imaging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Psychoactive Drug Screening (PDSP)
Psychoactive Drug Screening (PDSP)
Psychoactive Drug Screening (PDSP)
海外基金